---
title: "CytomX Therapeutics Chief Legal Officer Alejandra Carvajal files initial beneficial ownership statement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295029619.md"
description: "CytomX Therapeutics filed a Form 3 with the SEC for Chief Legal Officer Alejandra Carvajal, marking her initial beneficial ownership statement. The filing was published via EDGAR on August 5, 2026."
datetime: "2026-08-05T23:32:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295029619.md)
  - [en](https://longbridge.com/en/news/295029619.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295029619.md)
generator: "portal-rs"
---

# CytomX Therapeutics Chief Legal Officer Alejandra Carvajal files initial beneficial ownership statement

-   CytomX Therapeutics filed a Form 3 for Alejandra Carvajal, its chief legal officer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytomX Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000350), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CTMX.US](https://longbridge.com/en/quote/CTMX.US.md)

## Related News & Research

- [CytomX highlights Varseta-M EpCAM Topo-1 ADC data in late-line metastatic colorectal cancer presentation](https://longbridge.com/en/news/298356652.md)
- [CTMX: Lead ADC shows robust efficacy in late-line CRC, with pivotal study and new data expected this year](https://longbridge.com/en/news/298482685.md)
- [Interactive Strength files Form 3 showing Thomas Barclay Aulet stake of 791,735 shares](https://longbridge.com/en/news/298598501.md)
- [Zenas BioPharma files Form 3 showing InnoCare Pharma stake of 7 million shares](https://longbridge.com/en/news/298305393.md)
- [Satellogic files Form 3 initial beneficial ownership statement for President Frank Dixon Whitworth III](https://longbridge.com/en/news/298639569.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**